132 related articles for article (PubMed ID: 2363412)
1. Bone marrow in vitro growth and cytogenetic studies in patients with FAB-classified primary myelodysplastic syndromes.
Swolin B; Rödjer S; Westin J
Am J Hematol; 1990 Jul; 34(3):175-80. PubMed ID: 2363412
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous colony forming ability in vitro of the abnormal clone-derived granulocyte-macrophage precursors in myelodysplastic syndromes.
Okuda T; Yokota S; Maekawa T; Sonoda Y; Misawa S; Takino T; Abe T
Leuk Res; 1988; 12(8):687-92. PubMed ID: 3184986
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic values of in vitro culture growth patterns of marrow granulocyte-macrophage progenitors in patients with myelodysplastic syndrome.
Shih LY; Chiu WF; Lee CT
Leukemia; 1991 Dec; 5(12):1092-8. PubMed ID: 1774958
[TBL] [Abstract][Full Text] [Related]
4. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
Dan K; An E; Futaki M; Inokuchi K; Gomi S; Yamada T; Ogata K; Tanabe Y; Ohki I; Shinohara T
Acta Haematol; 1993; 89(3):113-8. PubMed ID: 8362599
[TBL] [Abstract][Full Text] [Related]
5. [The implications of the biological indices examination of bone marrow cells in myelodysplastic syndromes].
Zhang F; Hao Y; Pang W
Zhonghua Xue Ye Xue Za Zhi; 2001 Oct; 22(10):528-32. PubMed ID: 11769678
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes.
Geissler K; Hinterberger W; Jäger U; Bettelheim P; Neumann E; Haas O; Ambros P; Chott A; Radaszkiewicz T; Lechner K
Blut; 1988 Jul; 57(1):45-9. PubMed ID: 3390617
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow cultures and prognosis in primary myelodysplastic syndromes.
Korthout M; De Bock R; van Bockstaele D; Peetermans M
Leuk Res; 1990; 14(1):85-9. PubMed ID: 2304356
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of in vitro characteristics of colony-forming cells in myelodysplastic syndrome and comparison with that in non-severe aplastic anemia].
Zhang TJ; Feng M; Zheng YZ; Li XX; Xu ZF; Qin TJ; Zhang Y; Yang YB; Liu JX; Ren YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):516-21. PubMed ID: 22967409
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z
Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960
[TBL] [Abstract][Full Text] [Related]
10. Variable growth in vitro of chromosomally different stem cells in myelodysplastic syndromes.
Swolin B; Kristiansen IH; Rödjer S; Hellström-Lindberg E
Leuk Res; 1993 Nov; 17(11):927-32. PubMed ID: 8231233
[TBL] [Abstract][Full Text] [Related]
11. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
12. Hematological features of patients with myelodysplastic syndromes associated with a chromosome 5q deletion.
Lewis S; Oscier D; Boultwood J; Ross F; Fitchett M; Rack K; Abrahamson G; Buckle V; Wainscoat JS
Am J Hematol; 1995 Jul; 49(3):194-200. PubMed ID: 7604812
[TBL] [Abstract][Full Text] [Related]
13. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome.
Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L
Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797
[TBL] [Abstract][Full Text] [Related]
14. Colony-forming unit cell (CFU-C) assays at diagnosis: CFU-G/M cluster predicts overall survival in myelodysplastic syndrome patients independently of IPSS-R.
Li B; Liu J; Qu S; Gale RP; Song Z; Xing R; Liu J; Ren Y; Xu Z; Qin T; Zhang Y; Fang L; Zhang H; Pan L; Hu N; Cai W; Zhang P; Huang G; Xiao Z
Oncotarget; 2016 Oct; 7(42):68023-68032. PubMed ID: 27655727
[TBL] [Abstract][Full Text] [Related]
15. Prognostic implication of sequential bone marrow cultures in the myelodysplastic syndromes.
Yoshida Y; Yoshida C; Tohyama K; Ohmori S; Ohmori M; Ueda Y; Taniguchi Y; Uchino H
Leuk Res; 1989; 13(11):967-72. PubMed ID: 2607778
[TBL] [Abstract][Full Text] [Related]
16. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
[TBL] [Abstract][Full Text] [Related]
17. [Cytogenetic examination of bone marrow cells in stem cell diseases of myelodysplastic syndromes].
Werner M; Maschek HJ; Kaloutsi V; Buhr T; Kausche F; Delventhal S; Georgii A
Verh Dtsch Ges Pathol; 1990; 74():139-43. PubMed ID: 1708572
[TBL] [Abstract][Full Text] [Related]
18. MDS-macrophage derived inhibitory activity on myelopoiesis of MDS abnormal clones.
Ohmori S; Ohmori M; Yamagishi M; Okuma M
Br J Haematol; 1993 Mar; 83(3):388-91. PubMed ID: 8485044
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of granulocyte-macrophage colony formation in chronic myelomonocytic leukemia: a comparative study with other myelodysplastic and myeloproliferative disorders.
Yuo A; Miyazono K; Urabe A; Takaku F
Jpn J Cancer Res; 1990 Aug; 81(8):820-6. PubMed ID: 2118895
[TBL] [Abstract][Full Text] [Related]
20. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
